Loading clinical trials...
Loading clinical trials...
This is an international, multi-center, prospective, open-label, non-comparative study to provide EryDex treatment to ataxia telangiectasia (A-T) patients who complete the IEDAT-04-2022 trial on the n...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Quince Therapeutics S.p.A.
Collaborators
NCT05692596 · Pancreatic Ductal Adenocarcinoma, Pancreatic Cyst, and more
NCT03563053 · Ataxia Telangiectasia, Genetic Syndrome
NCT05252819 · Ataxia Telangiectasia
NCT04991701 · Ataxia Telangiectasia
NCT04037189 · Ataxia Telangiectasia, Leukemia, and more
University of California Los Angeles (UCLA), Ataxia Center and HD Center of excellence
Los Angeles, California
The Johns Hopkins Hospital, Division of pediatric allergy and immunology
Baltimore, Maryland
Saint Peter's University Hospital, Inc.
New Brunswick, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions